Categories

Tag: Uncategorized

QUALIITY: Says here that Doctors read the news!

Over at DB’s Medical Rants Robert has responded  to my gentle chiding and has written a nice piece regarding what’s wrong (in his view) with Wampum’s piece on malpractice.  (Note that he got up at 4 am to write it too! Who’d be an intensive internist?)

He’s also alerted me (and you) to a very interesting report about how doctors changed their behavior after the results of the two big trials on HRT and Alpha Blockers in the last couple of years. (Reuters release here but both full articles are unusually available for free from JAMA via my earlier links). The findings suggest that doctors do indeed respond in their prescribing habits to the latest evidence, particularly if the results of the trial are blared all over the press. This just makes the whole conversation over evidence based medicine more and more confusing.  How come doctors change practice on a dime over the HRT study but take years and years to apply some of the best practices elsewhere . . . . . I think Robert’s deliberately trying to make my future article about this harder to write!

PHARMA: GSK says to contest $5.2 billion U.S. tax claim

Just in case you thought you had tax troubles, the IRS thinks that GlaxoSmithKline owes it $5.2 billion. GSK has about $2bn in reserves to pay this, but obviously will be in tax court for a few years whittling this number down.  Given the way the stock market works the relative certainty of this upper limit may end up being a positive thing for GSK, and I doubt that rest of us will be passing the collection hat for them any time soon!

QUALITY: IOM meeting focuses on asthma, other key areas while Berwick puts it to the sword

The IOM just held a two day meeting to follow up on the 2001 report on Crossing the Chasm, which focused on the quality of chronic care management. This meeting focused on how to make real improvements in the areas of Asthma, Depression, Diabetes, Heart Failure and Pain Control. (I presume that no one from the DEA was there to discuss how locking up doctors improves pain control). Don Berwick was there and gave what sounds a pretty raucous speech about how we’re wasting our money in the health system.  If you haven’t read his speech called Escape Fire, then take a few minutes and do so.

QUALITY: More on malpractice

Stephen Schoenbaum and Randall Bobjerg, from the Commonwealth Fund and the Urban Institute respectively, probably just got themselves crossed off the AMA’s Christmas card list by publishing  this article in the Annals of Internal Medicine.  They suggest that doctors are paying too much attention to malpractice and not enough to actually improving patient safety.  In case you missed the point, Schoenbaum, an ex-Exec at Harvard Community Health Plan, one of the "good guys" HMOs is quoted in this interview as saying "All the discussion is about how do we minimize the impact of the suits rather than how do we minimize the number of suits". He also points out that certain groups of physicians, notably anesthesiologists,  have improved their patient safety activities over time leading to the question of why other specialists have not.

I’m going to waffle as to whether greater efforts by specialists to improve patient safety would be immediately effective, given my fuzzy position on whether evidence based medicine is easily-attainable in the real world (see yesterday’s post on appendectomy failure rates).  But it is fair to say that if some of the energy physicians spend on malpractice reform was redirected towards patient safety issues, we’d all be better off.

INDUSTRY: Malpractice at Wampum, with UPDATE

An interesting little storm is brewing over at Wampum about malpractice and its role in the latest Tort reform issue. There’s a lot of lefty and righty rhetoric in the comments, and I stuck my 2 cents in about the lack of attention to the defensive medicine issue–which is the only really meaningful and substantial part of the whole debate.  Of course, legislation doesn’t always get passed in this country because of keen insights into meaningful or substantial issues.  However, you should read the whole thing in order to see where the political arguments lie (pun intended).

While you’re there the Koufax awards are a great source for intros into some of the best political blogging on the left side of the American spectrum. (I’m a Brit so I have to use that qualifier!)

UPDATE: DB’s Medical Rants has a quick comment on Wampum’s piece, but the most intelligent pieces are in his comments.

QUALITY: Appendix surgery, too often needless but inevitably so?

I am determined to get back to the conversation on evidence based medicine that I was having with Robert Cantor over at Medical Rants before the holidays. Sadly I’m too gummed up with other work to finish the thoughtful response his last reply to me deserves–although I have subsequently interviewed Michael Millenson, the bete noir of the EBM-deniers (if that’s a term!), who’s last piece The Silence took a pretty hard line with the IOM for not being as aggressive as it should be on the topic.  More to come on that later.

But I remind you that I started this by discussing why evidence-based medicine was so hard to achieve in real world  practice.  This balanced article from the Boston Globe shows that big city hospitals which do lots of procedures on kids do better on reducing the false positive rate for pediatric appendectomies than lower volume hospitals. It seems that it’s pretty hard to get the mistake rate of the big city med centers (still up at around 4.8%) at the local hospital where they don’t see so many and have twice the error rate. The key point in the Pediatrics abstract that’s not in the write up for the lay reader is that two thirds of these pediatric appendectomies are done at the lower volume hospitals, and therefore have the worse results. Yet how many parents want to drive an extra hour or so to a distant hospital when their child is in pain? Does the "centers of excellence" concept make sense for this relatively trivial level of surgery? Is an 8% error level acceptable when the cost is more likely to be financial than medical?  It’s still a tough subject. 

I shall vent later mostly about information use, and this study provides useful information on how we should be tackling this type of procedure.  But it’s a bigger system change to move this type of surgery than to get all the transplants, say,  to high-volume physicians.

PHARMA: Drug stocks low risk in the new year?

The AP reported on New Year’s Eve that the rough consensus of analysts is that 2004 will be a reasonable but not great year for the pharma stocks. Those stocks have of course underperformed the S&P over the last year but actually haven’t done too badly over the last 2 years compared to the S&P after their plunge 18 months ago. One potential major problem has been dodged, with a Medicare bill that’s as friendly to the pharmas as possible.  The longer term problem is the paucity of the pipelines, so I’d look for more deals in the biotech sector like the one Pfizer did with Esperion Therapeutics. But of course some time after 2006 when the Medicare coverage comes in, the likelihood of more governenment interference is a risk in the much longer term.

In the shorter term the most interesting stock remains Astra-Zeneca. Since its beautiful technical double bottom in February and March last year A-Z has rallied over 65%.  THCB has reported at length about the potential problems with both Crestor and its struggles with Lipitor. This past weekend the influential finance magazine Barrons essentially came out  warning that A-Z’s rally was overdone, but if you’d shorted A-Z a few months ago when this discussion started, you would be under water. Is it any different now?

HAPPY NEW YEAR

Welcome to 2004 at THCB.  I hope to do a revamp to the site in the next few weeks, but I don’t think you’ll see too much change to the way things are run. I don’t think I’ll be adding comments, but please keep those emails coming and please feel free to write pieces that fit into the spirit of THCB. I’ll keep posting them if they’re suitable, whether or not I agree with them. Also please let me know if there are other topics you’d like to see covered in the future.

And in the spirit of New Year Renewal for some years now I’ve written an end of year letter suggesting some charities and issues that I’m supporting. It has nothing to do with health care, but if you’ve got some time I’d be delighted if you took a look and supported some of the charities and causes I feature.

HAPPY NEW YEAR

Thanks for reading THCB in 2003. I’m off to see if my knee will hold up to a little gentle snowboarding.  See you next week and happy 2004.

INTERNATIONAL/INDUSTRY–British Surgeons’ Private Fees Highest in World, really?

And in a fun story at the end of the year, Reuters claims that in their private practice British Surgeons charge the Highest fees in the World.  Now I know a little about this given that my father was, until his retirement last year, one of those NHS surgeons who worked 20% time in the private sector.  No question that the private sector was where he made the majority of his income (usually more than double there what he made in his relatively paltry NHS income), and there’s always been some controversy over this arrangement.  But although private fees were high there I’m very surprised that they were really higher than in the US, and specialists there make overall nothing like what specialists here do.  Last year the surgeon fee alone for my serious knee operation was, list price including assistant,  $21,500, and after I negotiated it down to roughly UCR, it was still around $12,000, or $10,000 for the surgeon’s fees alone.  Of course this didn’t count the tissue graft acquisition which was another $5,000 which I’m sure the surgeon’s office made a pass thru on. That was a for a three hour major but relatively routine surgical procedure.

So I asked my dad if he made 6,000 GBP equivalent of $10,000 for the average 3hr period he spent on this private operations and here’s the transcript of his response. "No (bleep) (bleep) (bleep) (bleep)(bleep) (bleep)ing (bleep), and you can (bleep) (bleep) in your (bleep)ing (bleep) and if I did I’d have (bleep)(bleep) (bleep)ing Ferrari, (bleep)(bleep) yacht (bleep)(bleep) house in south of France (bleep)(bleep) private jet (bleep)ing too".  So as they say in the medical literature, perhaps more research is needed!

assetto corsa mods